Follows state-supported schemes in Europe to combat resistance to antibiotics
Decision to retire comes two months after publication of Francis report into hospital scandal
Concerns about future of Cancer Drugs Fund
Will fall $1.6bn in value by 2020, say analysts GlobalData
Gains final backing to treat NHS patients with macular oedema
National Agency for the Safety of Drugs and Health Products contradicts PRAC verdict
CRO says new office will bolster its presence in the Middle East and North Africa
Inotuzumab ozogamicin fails to show survival benefit in phase III
Informational source shift: from marketing to medicalThe changing role of medical information in HCP communications pathways
Chasing the cure for Parkinson's diseaseResearch for this common neurodegenerative disease has made remarkable progress over the last decade, but current therapies can only reduce its symptoms
From paralysis to analysis: the journey to multichannel marketingTo make most of multichannel strategy, companies must be proactive and pull multichannel planning into the strategic process much earlier
Actavis to buy Warner Chilcott in $8.5bn dealCombined company will have annual revenues of about $11bn
OrphanReach alliance will see companies provide product lifecycle services
New vortioxetine studies reinforce efficacy in depressionSupports marketing applications from Takeda and Lundbeck
India puts cost controls on medicinesDrugs (Prices Control) Order 2013 reduces price of hundreds of drugs
Sanofi reconsiders closure plans in Toulouse after government pressureReport says research site can remain open with minimal job losses
PMEA 2013 opens for entryProgramme recognises responsible marketing and business practice in the healthcare industry
EMA says Bayer's Diane 35 should remain on European marketAgency investigation concludes acne treatment's benefits outweigh its risks
Boehringer's Wolfram Carius to step downHe will be replaced by Wolfgang Baiker on the board of managing directors
Canada role for UCB's Hervé Lilliu Appointed general manager of biopharma company’s operations in the country
Former NICE chair joins board of biotechSir Michael Rawlins joins board of Intra-Cellular Therapeutics
Lundbeck's Steve Turley re-elected as EMG chairAnd Actelion's Robin Bhattacherjee retains vice-chair position
VC firm expands team, appoints Genzyme and Lilly veteransNew roles for James Geraghty, Steven Paul, Daniel Lynch and John Maraganore
Incuna is one of the leading international digital healthcare agencies, working in both the global health and pharmaceutical sectors. Based ...